PDF
Corrigendum | Open Access
Neda Rajamand Ekberg, Sofie Eliasson, Young Wen Li, Xiaowei Zheng, Katerina Chatzidionysiou, Henrik Falhammar, Harvest F. Gu, Sergiu-Bogdan Catrina, "Corrigendum to “Protective Effect of the HIF-1A Pro582Ser Polymorphism on Severe Diabetic Retinopathy”", Journal of Diabetes Research, vol. 2021, Article ID 9827150, 1 page, 2021. https://doi.org/10.1155/2021/9827150
Corrigendum to “Protective Effect of the HIF-1A Pro582Ser Polymorphism on Severe Diabetic Retinopathy”
Neda Rajamand Ekberg,1,2,3 Sofie Eliasson,2 Young Wen Li,2,4 Xiaowei Zheng
,2 Katerina Chatzidionysiou,1 Henrik Falhammar,1,2 Harvest F. Gu,5 and Sergiu-Bogdan Catrina1,2,31Department of Endocrinology Metabolism and Diabetes, Karolinska University Hospital, Stockholm, Sweden
2Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden
3Centrum for Diabetes, Academic Specialist Centrum, Stockholm, Sweden
4Department of Pharmacology, Guilin Medical University, Guilin, China
5School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
In the article titled “Protective Effect of the HIF-1A Pro582Ser Polymorphism on Severe Diabetic Retinopathy” [1], the sentence “A total of 703 participated in the genetical analysis” in Section 2.1 should be corrected to “A total of 850 patients agreed and gave their informed consent before the enrolment in the study, and a total of 703 participated in the genetical analysis.”
The authors clarified that 850 patients were enrolled in the study, but blood samples for the genetic analysis were only available in 703 patients; therefore, the genetic association study was only performed on these 703 patients.
References
- N. R. Ekberg, S. Eliasson, Y. W. Li et al., “Protective Effect of the HIF-1A Pro582Ser Polymorphism on Severe Diabetic Retinopathy,” Journal of Diabetes Research, vol. 2019, Article ID 2936962, 8 pages, 2019. View at: Publisher Site | Google Scholar
Copyright
Copyright © 2021 Neda Rajamand Ekberg et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
